Brief: Cereno Scientific Extends Patent Protection For Drug Candidate CS1 In U.S.
17/03/2025 07:32
March 17 (Reuters) - Cereno Scientific AB CRNOSb.ST: CERENO SCIENTIFIC EXTENDS PATENT PROTECTION FOR DRUG CANDIDATE CS1 IN THE US AND HAS FILED TO EXTEND MARKET EXCLUSIVITY TO 2045 Source text: ID:nWkr8mkWz8 Further company coverage: [CRNOSb.ST] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Cereno Scientific AB
See all newsBrief: Cereno Scientific Expects Up To 15 Activated Sites By 2026 In Epimode Trial
Brief: Cereno Scientific Reports Positive Results From Study
Brief: Cereno Scientific Q2 Net Sales Sek 0
Sweden's Cereno Scientific Q2 net loss widens, hurt by clinical development costs
Brief: Cereno Scientific Q2 Loss After Financial Items SEK 30.5 Mln